Schoedon G, Schneemann M, Walter R, Blau N, Hofer S, Schaffner A
Department of Medicine, University of Zürich Medical School, Switzerland.
Clin Infect Dis. 1995 Oct;21 Suppl 2:S152-7. doi: 10.1093/clinids/21.supplement_2.s152.
Nitric oxide (NO) has been nicknamed "murderer" and "mediator" because it has toxic and signaling properties. We review these two aspects of NO synthesis from the perspective of the clinical infectious disease specialist by considering the potential of NO as an endothelium-derived relaxing factor (EDRF) in inflammation and sepsis and its potential as an antimicrobial system. We deviate from observations in recent authoritative reviews and point to important species differences that make it unlikely that NO serves as an EDRF mediating inflammatory vasodilatation in humans or that NO synthesized by humans phagocytes has an antimicrobial function. We propose that in humans, No synthesis is more confined and compartmentalized than in certain other animal species, and therefore, unwelcome toxicity, vasodilatation, or disturbance of paracrine signaling mechanisms (i.e., modulation of phagocytic cell functions) are avoidable during inflammation.
一氧化氮(NO)因其具有毒性和信号传导特性而被昵称为“杀手”和“介质”。我们从临床传染病专家的角度回顾了NO合成的这两个方面,考虑了NO作为炎症和脓毒症中内皮源性舒张因子(EDRF)的潜力及其作为抗菌系统的潜力。我们与近期权威综述中的观点不同,指出了重要的物种差异,这使得NO不太可能作为介导人类炎症性血管舒张的EDRF,或者人类吞噬细胞合成的NO不太可能具有抗菌功能。我们提出,在人类中,NO的合成比某些其他动物物种更受限制且更具区室化,因此,在炎症期间可避免不必要的毒性、血管舒张或旁分泌信号传导机制的紊乱(即吞噬细胞功能的调节)。